110 related articles for article (PubMed ID: 8588208)
21. Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer.
Ozyilkan O; Baltali E; Ozdemir O; Tekuzman G; Kirazli S; Firat D
Tumori; 1998; 84(3):364-7. PubMed ID: 9678618
[TBL] [Abstract][Full Text] [Related]
22. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
23. Plasma proteolytic activity in liver transplant rejection.
Scholz T; Gallimore MJ; Bäckman L; Mathisen O; Bergan A; Klintmalm GB; Aasen AO
Transpl Int; 1999; 12(2):100-7. PubMed ID: 10363591
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.
Masago K; Fujita S; Mio T; Togashi Y; Kim YH; Hatachi Y; Fukuhara A; Irisa K; Sakamori Y; Mishima M
Med Oncol; 2011 Mar; 28(1):351-6. PubMed ID: 20300980
[TBL] [Abstract][Full Text] [Related]
25. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
26. Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty.
Biagini D; Filippucci E; Agnelli G; Pagliaricci S
Thromb Res; 2004; 113(3-4):211-5. PubMed ID: 15140585
[TBL] [Abstract][Full Text] [Related]
27. The dynamics and clinical significance of alpha 2 plasmin inhibitor-plasmin complex and thrombin-antithrombin complex in postoperative pleural effusion following a pulmonary lobectomy.
Shoji F; Yano T; Yoshino I; Kawano D; Takenaka T; Miura N; Ito K; Morodomi Y; Maehara Y
Surg Today; 2009; 39(4):320-5. PubMed ID: 19319640
[TBL] [Abstract][Full Text] [Related]
28. Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy.
Uchiyama T; Matsumoto M; Kobayashi N
Thromb Res; 1990 Sep; 59(6):955-65. PubMed ID: 2148228
[TBL] [Abstract][Full Text] [Related]
29. Hemostatic markers in patients at risk of cerebral ischemia.
Côté R; Wolfson C; Solymoss S; Mackey A; Leclerc JR; Simard D; Rouah F; Bourque F; Léger B
Stroke; 2000 Aug; 31(8):1856-62. PubMed ID: 10926947
[TBL] [Abstract][Full Text] [Related]
30. Thrombin-antithrombin complex and alpha-plasmin inhibitor-plasmin complex levels in singleton and twin pregnancies.
Hayashi M; Fukasawa I; Inaba N
Int J Clin Pract; 2006 Oct; 60(10):1244-9. PubMed ID: 16669831
[TBL] [Abstract][Full Text] [Related]
31. Activation of thrombosis and fibrinolysis following brain infarction.
Kataoka S; Hirose G; Hori A; Shirakawa T; Saigan T
J Neurol Sci; 2000 Dec; 181(1-2):82-8. PubMed ID: 11099716
[TBL] [Abstract][Full Text] [Related]
32. Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment.
Tomura S; Nakamura Y; Deguchi F; Ando R; Chida Y; Marumo F
Thromb Res; 1991 Oct; 64(1):81-90. PubMed ID: 1776141
[TBL] [Abstract][Full Text] [Related]
33. Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis.
Matsuo T; Yamada T; Matsuo M; Sakai R
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):185-91. PubMed ID: 1751668
[TBL] [Abstract][Full Text] [Related]
34. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
[TBL] [Abstract][Full Text] [Related]
35. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
36. Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kulik S; Głuszczak M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):641-6. PubMed ID: 2465244
[TBL] [Abstract][Full Text] [Related]
37. Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis.
Inoh M; Tokuda M; Kiuchi H; Kurata N; Takahara J
Arthritis Rheum; 1996 Feb; 39(2):287-91. PubMed ID: 8849381
[TBL] [Abstract][Full Text] [Related]
38. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.
Minamikawa K; Wada H; Wakita Y; Ohiwa M; Tanigawa M; Deguchi K; Hiraoka N; Huzioka H; Nishioka J; Hayashi T
Thromb Haemost; 1994 Feb; 71(2):192-4. PubMed ID: 7514816
[TBL] [Abstract][Full Text] [Related]
39. Activation of intravascular coagulation in Bell's palsy.
Omori H; Ikeda M; Kukimoto N; Kawamoto H; Ikui A; Tomita H
Eur Arch Otorhinolaryngol; 1994 Dec; ():S471-2. PubMed ID: 10774425
[No Abstract] [Full Text] [Related]
40. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
AMBRUS CM; MARKUS G
Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
